Diwan Zoya, Trikha Sanjay, Etemad-Shahidi Sepideh, Parrish Nina, Rennie Christopher
Dr. Diwan is the President of Academic Aesthetics Mastermind Group and the Medical Director at Trikwan Aesthetics in London, United Kingdom.
Dr. Trikha is the Vice President of Academic Aesthetics Mastermind Group and the Director at Trikwan Aesthetics in London, United Kingdom.
J Clin Aesthet Dermatol. 2023 Jul;16(7):26-33.
The current popularity of dermal filler treatments as an alternative to invasive surgical cosmetic procedures has led to an increase in filler-related complications. Lip filler treatments are among the most sought-after injectable treatments and a thorough understanding of the complications of lip filler injections, and their management, is essential for any practitioner.
The aim of this review is to evaluate the current literature on complications secondary to lip augmentation following non-permanent dermal fillers.
A thorough MEDLINE literature search of keywords, including lip filler, augmentation, injection, filler, dermal filler, and complications, was completed to collate cases of complications secondary to lip filler injections.
Of our 53 cases that were studied, 82 complications were reported. Our review and evaluation of these cases showed that HA filler was most commonly used in this region, alone or in combination with other soft tissue fillers. The majority of complications resulted from HA involvement, however its frequency of use likely accounts for this. Across all three filler types, the most common complication was nodule formation. Other complications, such as migration, discoloration and herpetic outbreaks, have been linked with filler placement in the lip area.
It is clear that filler treatments carry a variety of risks, thus it becomes of utmost importance to truly understand the product we are working with, its properties, its associated risks, and how to manage those risks. We have to ensure that patients are adequately informed about the risks associated, and understand what those risks entail.
目前,真皮填充剂治疗作为侵入性外科美容手术的替代方法广受欢迎,这导致了与填充剂相关的并发症增多。唇部填充治疗是最受欢迎的注射治疗之一,对于任何从业者来说,全面了解唇部填充注射的并发症及其处理方法至关重要。
本综述的目的是评估有关非永久性真皮填充剂丰唇后并发症的现有文献。
通过对包括唇部填充剂、丰唇、注射、填充剂、真皮填充剂和并发症等关键词进行全面的医学文献数据库(MEDLINE)检索,以整理唇部填充注射继发并发症的病例。
在我们研究的53例病例中,共报告了82例并发症。我们对这些病例的回顾和评估表明,透明质酸(HA)填充剂在该区域最常单独使用或与其他软组织填充剂联合使用。大多数并发症是由HA引起的,不过其使用频率可能导致了这种情况。在所有三种填充剂类型中,最常见的并发症是结节形成。其他并发症,如迁移、变色和疱疹爆发,与填充剂在唇部区域的注射有关。
显然,填充剂治疗存在多种风险,因此真正了解我们所使用的产品、其特性、相关风险以及如何管理这些风险变得至关重要。我们必须确保患者充分了解相关风险,并明白这些风险意味着什么。